Hyperkalemia and Renin–Angiotensin–Aldosterone System Inhibitors Dose Therapy in Heart Failure With Reduced Ejection Fraction

Renin–angiotensin–aldosterone system inhibitors (RAASi) are known to improve outcomes in patients who have heart failure with reduced ejection fraction (HFrEF). To reduce mortality in these patients, RAASi should be uptitrated to the maximally tolerated dose. However, RAASi may also cause hyperkalem...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Card Fail Rev
Asıl Yazarlar: Rosano, Giuseppe MC, Spoletini, Ilaria, Vitale, Cristiana, Agewall, Stefan
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Radcliffe Cardiology 2019
Konular:
Clinical Practice
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6848927/
https://ncbi.nlm.nih.gov/pubmed/31768268
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15420/cfr.2019.8.2
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller